...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Research policy >Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D
【24h】

Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D

机译：在治疗的比赛中取得成就：非营利组织如何融资生物医学研发

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

In recent years, nonprofit firms focused on specific diseases have increased their grantmaking efforts in the search of a cure. They have become more aggressive in directly funding research and lobbying for public support, even if their cause affects a small number of people. This paper contributes to the literatures on R&D financing by developing the first production function for disease and medical research nonprofits, a growing hinder of biomedical R&D. Using IRS data, the model estimates the role of market competition and firm demographics on the adoption of grantmaking and lobbying strategies. Most notably, results provide evidence that firms in more geographically concentrated (less competitive markets) are more likely to adopt a lobbying strategy and less likely to be grantmaking on the extensive margin. Descriptive cases also illustrate funding discrepancies between charitable and government support across disease prevalence.
机译：近年来，非营利组织专注于特定疾病的公司在寻求治愈方面提高了他们的授予努力。即使他们的原因影响了少数人，他们也在直接资助研究和游说方面变得更加积极。本文通过开发疾病和医学研究非营利组织的第一个生产功能，促进了研发融资的文献，越来越多的生物医学研发。使用IRS数据，该模型估计市场竞争和牢固人口统计数据对采用授予和游说策略的作用。最值得注意的是，结果提供了证据，即在更多地理上集中（竞争性市场较低）的公司更有可能采用游说策略，并且不太可能在广泛的利润范围内受到授予。描述性案例还说明慈善和政府支持之间的差异差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号